Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients

Don Monath Sanjaya Kuruppu, Sherry H Y Chou, Steven K Feske, Sarah Suh, Iresha Hanchapola, Eng H Lo, Mingming Ning, Alexander Ian Smith

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Endothelin converting Enzyme-1 (ECE-1) is essential for the production of Endothelin-1 (ET-1), which is associated with vasospasm following subarachnoid hemorrhage (SAH). We have previously demonstrated the presence of a catalytically active soluble form of ECE-1 in the media of endothelial cells. We aimed to determine if this form of ECE-1 exists in vivo, in cerebrospinal fluid (CSF) of SAH patients. We examined CSF taken from SAH subjects for the presence of soluble ECE-1 using a bradykinin based quenched fluorescent substrate assay. We obtained further confirmation by characterizing the CSF mediated cleavage products of BigET and BigET18-34 (6 micrograms/mL) using mass spectrometry. The specificity of cleavage was confirmed using the ECE-1 inhibitor CGS35066 (5 micromol/L). The ECE-1 activity (Mean/SEM) in SAH CSF samples was 0.127/0.037 micromols of substrate cleaved/microlitre of CSF/24 hrs. The C-terminal peptides generated upon the cleavage of BigET and BigET18-34 were detected 48 hrs after incubation of these substrates with CSF. Cleavage of these substrates was inhibited by CGS35066. Results of western blots also produced strong evidence for the presence of truncated soluble ECE-1 in CSF. These results strongly suggest the presence of a truncated but catalytically active form of ECE-1 in the CSF of SAH subjects. Further studies are necessary to determine the biological significance of soluble ECE-1 in CSF of SAH subjects, including an association with vasospasm after SAH.
Original languageEnglish
Pages (from-to)1091 - 1094
Number of pages4
JournalMolecular & Cellular Proteomics
Volume13
Issue number4
DOIs
Publication statusPublished - 2014

Cite this

Kuruppu, Don Monath Sanjaya ; Chou, Sherry H Y ; Feske, Steven K ; Suh, Sarah ; Hanchapola, Iresha ; Lo, Eng H ; Ning, Mingming ; Smith, Alexander Ian. / Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients. In: Molecular & Cellular Proteomics. 2014 ; Vol. 13, No. 4. pp. 1091 - 1094.
@article{c1b161fc31d1467abc35cc8774071489,
title = "Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients",
abstract = "Endothelin converting Enzyme-1 (ECE-1) is essential for the production of Endothelin-1 (ET-1), which is associated with vasospasm following subarachnoid hemorrhage (SAH). We have previously demonstrated the presence of a catalytically active soluble form of ECE-1 in the media of endothelial cells. We aimed to determine if this form of ECE-1 exists in vivo, in cerebrospinal fluid (CSF) of SAH patients. We examined CSF taken from SAH subjects for the presence of soluble ECE-1 using a bradykinin based quenched fluorescent substrate assay. We obtained further confirmation by characterizing the CSF mediated cleavage products of BigET and BigET18-34 (6 micrograms/mL) using mass spectrometry. The specificity of cleavage was confirmed using the ECE-1 inhibitor CGS35066 (5 micromol/L). The ECE-1 activity (Mean/SEM) in SAH CSF samples was 0.127/0.037 micromols of substrate cleaved/microlitre of CSF/24 hrs. The C-terminal peptides generated upon the cleavage of BigET and BigET18-34 were detected 48 hrs after incubation of these substrates with CSF. Cleavage of these substrates was inhibited by CGS35066. Results of western blots also produced strong evidence for the presence of truncated soluble ECE-1 in CSF. These results strongly suggest the presence of a truncated but catalytically active form of ECE-1 in the CSF of SAH subjects. Further studies are necessary to determine the biological significance of soluble ECE-1 in CSF of SAH subjects, including an association with vasospasm after SAH.",
author = "Kuruppu, {Don Monath Sanjaya} and Chou, {Sherry H Y} and Feske, {Steven K} and Sarah Suh and Iresha Hanchapola and Lo, {Eng H} and Mingming Ning and Smith, {Alexander Ian}",
year = "2014",
doi = "10.1074/mcp.M113.027359",
language = "English",
volume = "13",
pages = "1091 -- 1094",
journal = "Molecular & Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology",
number = "4",

}

Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients. / Kuruppu, Don Monath Sanjaya; Chou, Sherry H Y; Feske, Steven K; Suh, Sarah; Hanchapola, Iresha; Lo, Eng H; Ning, Mingming; Smith, Alexander Ian.

In: Molecular & Cellular Proteomics, Vol. 13, No. 4, 2014, p. 1091 - 1094.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Soluble and catalytically active endothelin converting enzyme-1 is present in cerebrospinal fluid of subarachnoid hemorrhage patients

AU - Kuruppu, Don Monath Sanjaya

AU - Chou, Sherry H Y

AU - Feske, Steven K

AU - Suh, Sarah

AU - Hanchapola, Iresha

AU - Lo, Eng H

AU - Ning, Mingming

AU - Smith, Alexander Ian

PY - 2014

Y1 - 2014

N2 - Endothelin converting Enzyme-1 (ECE-1) is essential for the production of Endothelin-1 (ET-1), which is associated with vasospasm following subarachnoid hemorrhage (SAH). We have previously demonstrated the presence of a catalytically active soluble form of ECE-1 in the media of endothelial cells. We aimed to determine if this form of ECE-1 exists in vivo, in cerebrospinal fluid (CSF) of SAH patients. We examined CSF taken from SAH subjects for the presence of soluble ECE-1 using a bradykinin based quenched fluorescent substrate assay. We obtained further confirmation by characterizing the CSF mediated cleavage products of BigET and BigET18-34 (6 micrograms/mL) using mass spectrometry. The specificity of cleavage was confirmed using the ECE-1 inhibitor CGS35066 (5 micromol/L). The ECE-1 activity (Mean/SEM) in SAH CSF samples was 0.127/0.037 micromols of substrate cleaved/microlitre of CSF/24 hrs. The C-terminal peptides generated upon the cleavage of BigET and BigET18-34 were detected 48 hrs after incubation of these substrates with CSF. Cleavage of these substrates was inhibited by CGS35066. Results of western blots also produced strong evidence for the presence of truncated soluble ECE-1 in CSF. These results strongly suggest the presence of a truncated but catalytically active form of ECE-1 in the CSF of SAH subjects. Further studies are necessary to determine the biological significance of soluble ECE-1 in CSF of SAH subjects, including an association with vasospasm after SAH.

AB - Endothelin converting Enzyme-1 (ECE-1) is essential for the production of Endothelin-1 (ET-1), which is associated with vasospasm following subarachnoid hemorrhage (SAH). We have previously demonstrated the presence of a catalytically active soluble form of ECE-1 in the media of endothelial cells. We aimed to determine if this form of ECE-1 exists in vivo, in cerebrospinal fluid (CSF) of SAH patients. We examined CSF taken from SAH subjects for the presence of soluble ECE-1 using a bradykinin based quenched fluorescent substrate assay. We obtained further confirmation by characterizing the CSF mediated cleavage products of BigET and BigET18-34 (6 micrograms/mL) using mass spectrometry. The specificity of cleavage was confirmed using the ECE-1 inhibitor CGS35066 (5 micromol/L). The ECE-1 activity (Mean/SEM) in SAH CSF samples was 0.127/0.037 micromols of substrate cleaved/microlitre of CSF/24 hrs. The C-terminal peptides generated upon the cleavage of BigET and BigET18-34 were detected 48 hrs after incubation of these substrates with CSF. Cleavage of these substrates was inhibited by CGS35066. Results of western blots also produced strong evidence for the presence of truncated soluble ECE-1 in CSF. These results strongly suggest the presence of a truncated but catalytically active form of ECE-1 in the CSF of SAH subjects. Further studies are necessary to determine the biological significance of soluble ECE-1 in CSF of SAH subjects, including an association with vasospasm after SAH.

UR - http://www.mcponline.org/content/13/4/1091.full.pdf+html

U2 - 10.1074/mcp.M113.027359

DO - 10.1074/mcp.M113.027359

M3 - Article

VL - 13

SP - 1091

EP - 1094

JO - Molecular & Cellular Proteomics

JF - Molecular & Cellular Proteomics

SN - 1535-9476

IS - 4

ER -